Imperial College London

Dr Alex Miras

Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

Visiting Professor
 
 
 
//

Contact

 

+44 (0)7958 377 674a.miras

 
 
//

Location

 

Commonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Samarasinghe:2024:10.1016/j.metabol.2023.155745,
author = {Samarasinghe, SNS and Woods, C and Miras, AD},
doi = {10.1016/j.metabol.2023.155745},
journal = {Metabolism},
title = {Bariatric Surgery in Women with Polycystic Ovary Syndrome.},
url = {http://dx.doi.org/10.1016/j.metabol.2023.155745},
volume = {151},
year = {2024}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Polycystic ovary syndrome (PCOS) is the most common endocrine condition in premenopausal women and is a common cause of anovulatory subfertility. Although obesity does not form part of the diagnostic criteria, it affects a significant proportion of women with PCOS and is strongly implicated in the pathophysiology of the disease. Both PCOS and obesity are known to impact fertility in women; obesity also reduces the success of assisted reproductive technology (ART). With or without pharmacotherapy, lifestyle intervention remains the first-line treatment in women with PCOS and obesity. Bariatric surgery is still an experimental treatment in women with PCOS and subfertility. This review will present an overview of the pathophysiology of PCOS and obesity and the role of bariatric surgery. Although data are sparse regarding the impact of bariatric surgery on subfertility in women with PCOS and obesity, existing studies point to a beneficial role in treating metabolic and reproductive dysfunction.
AU - Samarasinghe,SNS
AU - Woods,C
AU - Miras,AD
DO - 10.1016/j.metabol.2023.155745
PY - 2024///
TI - Bariatric Surgery in Women with Polycystic Ovary Syndrome.
T2 - Metabolism
UR - http://dx.doi.org/10.1016/j.metabol.2023.155745
UR - https://www.ncbi.nlm.nih.gov/pubmed/38036245
VL - 151
ER -